Načítá se...
Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
Ichihashi et al reported that 43% of patients had antipsychotic polypharmacy. Number of antipsychotics used in patients with schizophrenia in Japan was the greatest among Asian countries. However, the antipsychotic polypharmacy rate in Japan decreased gradually. Recent systematic review, meta‐analys...
Uloženo v:
| Vydáno v: | Neuropsychopharmacol Rep |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7722682/ https://ncbi.nlm.nih.gov/pubmed/32672006 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/npr2.12127 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|